-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network, March 24th, this issue of HMAS medical institution market analysis system in-depth deconstruction of the Shanghai hospital drug market in 2020: under the influence of the epidemic and large-scale procurement, how will the hospital market at all levels and categories perform in 2020?
The tertiary hospital market scale is close to 50%
According to statistics from the HMAS medical institution market analysis system, in 2020, the size of the Shanghai medical institution market will be close to 55 billion yuan.
Among them, the first-tier hospital market accounted for 27%, the second-tier hospital market accounted for 24%, the third-tier hospital market accounted for 49%, and the third-tier hospital market accounted for about 5% compared to 2019.
Among them, the first-tier hospital market accounted for 27%, the second-tier hospital market accounted for 24%, the third-tier hospital market accounted for 49%, and the third-tier hospital market accounted for about 5% compared to 2019.
Figure 1 Market share of different levels of hospitals in Shanghai's hospital drug market in 2020
The overall market size has declined slightly
In 2020, the size of the Shanghai hospital market has declined due to the impact of the new crown epidemic.
According to the statistics of the HMAS medical institution market analysis system, the size of the Shanghai hospital market in 2020 is 54.
9 billion, suspending the rapid growth in recent years, compared with 2019 , A year-on-year decrease of 0.
87%.
According to the statistics of the HMAS medical institution market analysis system, the size of the Shanghai hospital market in 2020 is 54.
9 billion, suspending the rapid growth in recent years, compared with 2019 , A year-on-year decrease of 0.
87%.
Figure 2 2018-2020 Shanghai hospital drug market scale and growth performance
The size of the secondary hospital market has shrunk significantly
In 2020, the growth of the market size of hospitals at all levels is very different.
The growth rate of first-level hospitals is 2.
51%, slightly higher than the overall market; while the growth rate of second-level hospitals is -19.
3%, which is a sharp drop from the growth of 21.
75% in 2019.
It is also the main reason why the overall market has stopped growing; the growth rate of tertiary hospitals is 9.
63%, which is a significant increase in market share and growth rate compared to 2019.
The growth rate of first-level hospitals is 2.
51%, slightly higher than the overall market; while the growth rate of second-level hospitals is -19.
3%, which is a sharp drop from the growth of 21.
75% in 2019.
It is also the main reason why the overall market has stopped growing; the growth rate of tertiary hospitals is 9.
63%, which is a significant increase in market share and growth rate compared to 2019.
Figure 3 2019-2020 Shanghai hospital drug market different levels of hospital market growth performance
Anti -tumor drug market leader in all categories
In 2020, chemical drugs accounted for 75% of the hospital drug sales market in Shanghai, and proprietary Chinese medicines and biological preparations ranked second and third, accounting for 20% and 5%, respectively.
Figure 4 The proportion of different drug categories in the Shanghai hospital drug market in 2020
From the perspective of the treatment field, under the background of the overall market growth decline in 2020, half of the drug market size in the treatment field will show a negative growth.
Among them, the treatment field with a relatively high market share such as anti-infection and respiratory system will decline to a large extent.
Driven by the launch of innovative drugs and the rapid entry of medical insurance, anti-tumor drugs and immunomodulators are the fastest-growing therapeutic areas, followed by blood and hematopoietic organ drugs.
Among them, the treatment field with a relatively high market share such as anti-infection and respiratory system will decline to a large extent.
Driven by the launch of innovative drugs and the rapid entry of medical insurance, anti-tumor drugs and immunomodulators are the fastest-growing therapeutic areas, followed by blood and hematopoietic organ drugs.
Figure 5 The growth rate of different therapeutic areas in the Shanghai hospital drug market in 2020
Medical Network, March 24th, this issue of HMAS medical institution market analysis system in-depth deconstruction of the Shanghai hospital drug market in 2020: under the influence of the epidemic and large-scale procurement, how will the hospital market at all levels and categories perform in 2020?
The tertiary hospital market scale is close to 50%
According to statistics from the HMAS medical institution market analysis system, in 2020, the size of the Shanghai medical institution market will be close to 55 billion yuan.
Among them, the first-tier hospital market accounted for 27%, the second-tier hospital market accounted for 24%, the third-tier hospital market accounted for 49%, and the third-tier hospital market accounted for about 5% compared to 2019.
Among them, the first-tier hospital market accounted for 27%, the second-tier hospital market accounted for 24%, the third-tier hospital market accounted for 49%, and the third-tier hospital market accounted for about 5% compared to 2019.
Figure 1 Market share of different levels of hospitals in Shanghai's hospital drug market in 2020
The overall market size has declined slightly
In 2020, the size of the Shanghai hospital market has declined due to the impact of the new crown epidemic.
According to the statistics of the HMAS medical institution market analysis system, the size of the Shanghai hospital market in 2020 is 54.
9 billion, suspending the rapid growth in recent years, compared with 2019 , A year-on-year decrease of 0.
87%.
According to the statistics of the HMAS medical institution market analysis system, the size of the Shanghai hospital market in 2020 is 54.
9 billion, suspending the rapid growth in recent years, compared with 2019 , A year-on-year decrease of 0.
87%.
Figure 2 2018-2020 Shanghai hospital drug market scale and growth performance
The size of the secondary hospital market has shrunk significantly
In 2020, the growth of the market size of hospitals at all levels is very different.
The growth rate of first-level hospitals is 2.
51%, slightly higher than the overall market; while the growth rate of second-level hospitals is -19.
3%, which is a sharp drop from the growth of 21.
75% in 2019.
It is also the main reason why the overall market has stopped growing; the growth rate of tertiary hospitals is 9.
63%, which is a significant increase in market share and growth rate compared to 2019.
The growth rate of first-level hospitals is 2.
51%, slightly higher than the overall market; while the growth rate of second-level hospitals is -19.
3%, which is a sharp drop from the growth of 21.
75% in 2019.
It is also the main reason why the overall market has stopped growing; the growth rate of tertiary hospitals is 9.
63%, which is a significant increase in market share and growth rate compared to 2019.
Figure 3 2019-2020 Shanghai hospital drug market different levels of hospital market growth performance
Anti -tumor drug market leader in all categories
In 2020, chemical drugs accounted for 75% of the hospital drug sales market in Shanghai, and proprietary Chinese medicines and biological preparations ranked second and third, accounting for 20% and 5%, respectively.
Figure 4 The proportion of different drug categories in the Shanghai hospital drug market in 2020
From the perspective of the treatment field, under the background of the overall market growth decline in 2020, half of the drug market size in the treatment field will show a negative growth.
Among them, the treatment field with a relatively high market share such as anti-infection and respiratory system will decline to a large extent.
Driven by the launch of innovative drugs and the rapid entry of medical insurance, anti-tumor drugs and immunomodulators are the fastest-growing therapeutic areas, followed by blood and hematopoietic organ drugs.
Among them, the treatment field with a relatively high market share such as anti-infection and respiratory system will decline to a large extent.
Driven by the launch of innovative drugs and the rapid entry of medical insurance, anti-tumor drugs and immunomodulators are the fastest-growing therapeutic areas, followed by blood and hematopoietic organ drugs.
Figure 5 The growth rate of different therapeutic areas in the Shanghai hospital drug market in 2020
Medical Network, March 24th, this issue of HMAS medical institution market analysis system in-depth deconstruction of the Shanghai hospital drug market in 2020: under the influence of the epidemic and large-scale procurement, how will the hospital market at all levels and categories perform in 2020?
The tertiary hospital market scale is close to 50%
The tertiary hospital market scale is close to 50% According to statistics from the HMAS medical institution market analysis system, in 2020, the size of the Shanghai medical institution market will be close to 55 billion yuan.
Among them, the first-tier hospital market accounted for 27%, the second-tier hospital market accounted for 24%, the third-tier hospital market accounted for 49%, and the third-tier hospital market accounted for about 5% compared to 2019.
Among them, the first-tier hospital market accounted for 27%, the second-tier hospital market accounted for 24%, the third-tier hospital market accounted for 49%, and the third-tier hospital market accounted for about 5% compared to 2019.
Figure 1 Market share of different levels of hospitals in Shanghai's hospital drug market in 2020
The overall market size has declined slightly
The overall market size has declined slightly In 2020, the size of the Shanghai hospital market has declined due to the impact of the new crown epidemic.
According to the statistics of the HMAS medical institution market analysis system, the size of the Shanghai hospital market in 2020 is 54.
9 billion, suspending the rapid growth in recent years, compared with 2019 , A year-on-year decrease of 0.
87%.
According to the statistics of the HMAS medical institution market analysis system, the size of the Shanghai hospital market in 2020 is 54.
9 billion, suspending the rapid growth in recent years, compared with 2019 , A year-on-year decrease of 0.
87%.
Figure 2 2018-2020 Shanghai hospital drug market scale and growth performance
Medicine, medicine, medicine The size of the secondary hospital market has shrunk significantly
Two hospital hospital hospital market size significantly reduced In 2020, the growth of the market size of hospitals at all levels is very different.
The growth rate of first-level hospitals is 2.
51%, slightly higher than the overall market; while the growth rate of second-level hospitals is -19.
3%, which is a sharp drop from the growth of 21.
75% in 2019.
It is also the main reason why the overall market has stopped growing; the growth rate of tertiary hospitals is 9.
63%, which is a significant increase in market share and growth rate compared to 2019.
The growth rate of first-level hospitals is 2.
51%, slightly higher than the overall market; while the growth rate of second-level hospitals is -19.
3%, which is a sharp drop from the growth of 21.
75% in 2019.
It is also the main reason why the overall market has stopped growing; the growth rate of tertiary hospitals is 9.
63%, which is a significant increase in market share and growth rate compared to 2019.
Figure 3 2019-2020 Shanghai hospital drug market different levels of hospital market growth performance
Anti -tumor drug market leader in all categories
Anti- tumor tumor tumor drug market leader in all categories In 2020, chemical drugs accounted for 75% of the hospital drug sales market in Shanghai, and proprietary Chinese medicines and biological preparations ranked second and third, accounting for 20% and 5%, respectively.
Figure 4 The proportion of different drug categories in the Shanghai hospital drug market in 2020
From the perspective of the treatment field, under the background of the overall market growth decline in 2020, half of the drug market size in the treatment field will show a negative growth.
Among them, the treatment field with a relatively high market share such as anti-infection and respiratory system will decline to a large extent.
Driven by the launch of innovative drugs and the rapid entry of medical insurance, anti-tumor drugs and immunomodulators are the fastest-growing therapeutic areas, followed by blood and hematopoietic organ drugs.
Among them, the treatment field with a relatively high market share such as anti-infection and respiratory system will decline to a large extent.
Driven by the launch of innovative drugs and the rapid entry of medical insurance, anti-tumor drugs and immunomodulators are the fastest-growing therapeutic areas, followed by blood and hematopoietic organ drugs.
Figure 5 The growth rate of different therapeutic areas in the Shanghai hospital drug market in 2020
